Medical imaging and radiology
RapidAI
Enterprise imaging AI platform for acute and longitudinal clinical workflows, including FDA-cleared imaging modules.
Last updated: June 14, 2026
Back to directoryCercare Medical Neurosuite medical AI product profile
Vendor-neutral neuroimaging software that processes CT, MRI, and CBCT perfusion studies into clinician-reviewed hemodynamic maps and stroke-workflow outputs.
Medical imaging and radiology
Best fit
Hospitals that need regulated perfusion post-processing across stroke and neuroimaging workflows, especially teams evaluating angio-suite CBCT perfusion.
- Primary use case
- Automated CT, MRI, and cone-beam CT perfusion post-processing for stroke, neuro-oncology, and neurovascular assessment workflows
- Audience
- Stroke centers, neuroradiology teams, interventional suites, oncology imaging programs, and hospitals evaluating cerebral perfusion workflows
- Risk level
- High
- Pricing signal
- Enterprise and hospital pricing varies by module, region, modality, and integration; verify current CMN, CT/MRI perfusion, and CBCT Perfusion terms.
- Official sources
- 5 official sources
Compare within workflow: Medical imaging and radiology · comparison shortlist · source index
Regulatory snapshot
| Status | FDA-cleared image-processing software for CMN perfusion workflows, with company-stated FDA 510(k) K253831 clearance for CBCT Perfusion in 2026. |
|---|---|
| Review route | 510(k), including CMN Capillary Function with Virtual Expert MRI and CT K241989 and company-stated CBCT Perfusion K253831. |
| Intended use | Processes neuroimaging studies for trained professionals and supports visualization, quantification, analysis, and reporting of perfusion-related outputs; clinicians remain responsible for treatment decisions. |
| Verification note | Separate CT, MRI, CBCT, Capillary Function, Virtual Expert, oncology, and stroke claims in procurement review, and match each to the current FDA or regional authorization. |
| Source | cercare-medical.com / cercare-medical-receives-fda-510k-clearance-for-cone-beam-ct-perfusion |
Regulatory, privacy, evidence, and workflow lens
Product-specific review. These product-specific signals summarize what the cited sources imply before treating Cercare Medical Neurosuite as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Treat CMN as regulated image-processing decision support and verify each module separately because MRI, CT, Virtual Expert, and CBCT Perfusion clearances have different indications and workflow assumptions. |
|---|---|
| Privacy | Review DICOM metadata handling, PACS/RIS routing, remote desktop or virtual platform access, retention, support uploads, audit logs, cybersecurity documentation, and any cloud or distributor data-processing terms. |
| Evidence | Check FDA summaries, validation testing, local scanner protocols, perfusion-map comparability, reader agreement, and stroke-team outcomes before using outputs to change triage or treatment pathways. |
| Workflow | Best governed as a neuroradiologist- and stroke-team-reviewed perfusion layer, with explicit escalation, downtime, quality-control, and post-thrombectomy review procedures. |
Where Cercare Medical Neurosuite fits
Cercare Medical describes Neurosuite as vendor-neutral CT, MRI, and CBCT perfusion post-processing software for neurological imaging workflows; its May 2026 materials state that CBCT Perfusion received FDA 510(k) K253831 and CE-marked status, while FDA K241989 describes CMN Capillary Function with Virtual Expert for MRI and CT as decision-support software for trained professionals.
Not for: Autonomous diagnosis, use outside the cleared modality or intended use, or treatment decisions without trained clinician review and local validation.
What to verify before using Cercare Medical Neurosuite
- Which module is in scope: CMN Capillary Function, Virtual Expert, CT perfusion, MRI perfusion, CBCT Perfusion, oncology, or stroke workflow support.
- Whether FDA, CE, or local authorization covers the exact modality, scanner workflow, disease state, and output your clinicians plan to use.
- How DICOM routing, PACS integration, remote access, image retention, cybersecurity, and generated map storage work in your environment.
- Local performance for perfusion-map quality, threshold outputs, false reassurance risk, transfer timing, thrombectomy decision support, and radiologist or stroke-team review.
Source links
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.
- cercare-medical.com / solutions-services
- cercare-medical.com / cercare-medical-receives-fda-510k-clearance-for-cone-beam-ct-perfusion
- www.siemens-healthineers.com / press / releases
- www.accessdata.fda.gov / cdrh_docs / pdf24
- www.accessdata.fda.gov / cdrh_docs / pdf20
Related medical AI products
Medical imaging and radiology
Heartflow
Non-invasive AI heart-care platform for coronary CTA-derived anatomy, physiology, and plaque information.
Medical imaging and radiology
Caristo CaRi-Plaque and CaRi-Heart
Cardiac CT AI from Caristo that analyzes coronary CTA images for plaque, stenosis, inflammation, and risk reporting in clinician-reviewed workflows.
Medical imaging and radiology
Ultromics EchoGo
FDA-cleared echocardiography AI that analyzes apical four-chamber clips to support detection of heart failure with preserved ejection fraction.